RSV Vaccine Approved for Older Adults: A Breakthrough in Respiratory Protection
Understanding RSV and Why It's a Threat to Seniors
Respiratory Syncytial Virus (RSV) is a common respiratory virus that usually causes mild,cold-like symptoms. However, for older adults, RSV can led to severe illness, including pneumonia and hospitalization. Before the availability of a vaccine, RSV was estimated to cause approximately 60,000-160,000 hospitalizations and 6,000-10,000 deaths annually among adults 65 years and older in the United states.
The virus spreads through close contact with infected individuals, much like the common cold or flu. Symptoms can include a runny nose, cough, fever, and shortness of breath.Older adults are particularly vulnerable as their immune systems weaken with age, making them less able to fight off the infection effectively.